Welcome to our dedicated page for China Liberal Education Holdings SEC filings (Ticker: CLEU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on China Liberal Education Holdings's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into China Liberal Education Holdings's regulatory disclosures and financial reporting.
China Liberal Education Holdings Limited (CLEU) reported via Form 6-K that the Nasdaq Hearings Panel has denied the company’s request to remain listed on The Nasdaq Stock Market. Trading in CLEU shares was already suspended on 3 June 2025; the Panel’s written decision, dated 12 June 2025, confirms the delisting.
The ruling stems from two cited breaches: (1) Nasdaq Listing Rule 5250(c)(1) for failure to file the Form 20-F for the year ended 31 Dec 2024, and (2) Nasdaq Listing Rule 5101 public-interest concerns linked to a substantial ordinary-share issuance in Dec 2024. After reviewing the company’s submission and compliance history, the Panel concluded CLEU is “not suitable for continued listing.”
Since 3 June 2025 the ordinary shares have traded on the OTC Pink Current Market under ticker CLEUF. Management states the migration does not affect day-to-day operations and that the company intends to keep meeting its SEC reporting obligations. Nevertheless, an OTC quotation generally implies lower liquidity, reduced analyst coverage, and possible increases in capital-raising costs, all of which can materially affect existing and prospective shareholders.